Clinical challenges treating Stenotrophomonas maltophilia infections: an update
Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
[HTML][HTML] Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies
J Gibb, DW Wong - Antibiotics, 2021 - mdpi.com
Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
PKT Li, KM Chow, Y Cho, S Fan… - Peritoneal dialysis …, 2022 - journals.sagepub.com
Peritoneal dialysis (PD)-associated peritonitis is a serious complication of PD and
prevention and treatment of such is important in reducing patient morbidity and mortality …
prevention and treatment of such is important in reducing patient morbidity and mortality …
Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
R Kullar, E Wenzler, J Alexander… - Open Forum Infectious …, 2022 - academic.oup.com
Stenotrophomonas maltophilia is an underappreciated source of morbidity and mortality
among gram-negative pathogens. Effective treatment options with acceptable toxicity …
among gram-negative pathogens. Effective treatment options with acceptable toxicity …
[HTML][HTML] Stenotrophomonas maltophilia and Its Ability to Form Biofilms
G García, JA Girón, JA Yañez, ML Cedillo - Microbiology Research, 2022 - mdpi.com
In the last ten years, Stenotrophomonas maltophilia has gained increasing interest as an
important agent of infection, which is why it has come to be recognized as a serious cause of …
important agent of infection, which is why it has come to be recognized as a serious cause of …
[HTML][HTML] Epidemiology, mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria: an expert panel opinion
N Coppola, AE Maraolo, L Onorato, R Scotto, F Calò… - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …
[HTML][HTML] Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment …
AE Maraolo, F Licciardi, I Gentile, A Saracino, A Belati… - Antibiotics, 2023 - mdpi.com
Stenotrophomonas maltophilia (SM) represents a challenging pathogen due to its resistance
profile. A systematic review of the available evidence was conducted to evaluate the best …
profile. A systematic review of the available evidence was conducted to evaluate the best …
Stenotrophomonas maltophilia: An Urgent Threat with Increasing Antibiotic Resistance
J Liu, Y Xiang, Y Zhang - Current Microbiology, 2024 - Springer
Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can cause
many infections, such as chronic pulmonary infections in patients with cystic fibrosis and …
many infections, such as chronic pulmonary infections in patients with cystic fibrosis and …
Treatment approaches for severe Stenotrophomonas maltophilia infections
Treatment approaches for severe Stenotrophomonas maltophilia... : Current Opinion in
Infectious Diseases Treatment approaches for severe Stenotrophomonas maltophilia infections …
Infectious Diseases Treatment approaches for severe Stenotrophomonas maltophilia infections …
Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints
AJ Fratoni, DP Nicolau, JL Kuti - Journal of Antimicrobial …, 2022 - academic.oup.com
Background Minocycline displays high susceptibility rates against Stenotrophomonas
maltophilia at the current breakpoint of 4 mg/L. However, no pharmacodynamic data are …
maltophilia at the current breakpoint of 4 mg/L. However, no pharmacodynamic data are …